BIOMAT Database Logo BIOMAT Database Logo

Evidence that T-kinin does not mediate paw swelling induced by carrageenin: studies with plasma high molecular weight kininogen and low molecular weight kininogen deficient rats. 1987

S Oh-ishi, and I Hayashi, and I Utsunomiya, and M Hayashi, and K Yamaki, and A Yamasu, and T Nakano

UI MeSH Term Description Entries
D007704 Kininogens Endogenous peptides present in most body fluids. Certain enzymes convert them to active KININS which are involved in inflammation, blood clotting, complement reactions, etc. Kininogens belong to the cystatin superfamily. They are cysteine proteinase inhibitors. HIGH-MOLECULAR-WEIGHT KININOGEN; (HMWK); is split by plasma kallikrein to produce BRADYKININ. LOW-MOLECULAR-WEIGHT KININOGEN; (LMWK); is split by tissue kallikrein to produce KALLIDIN. Cystatins, Kininogen,Kininogen,Prekinins,Prokinins,T-Kininogen,Thiostatin,Kininogen Cystatins,T Kininogen
D008970 Molecular Weight The sum of the weight of all the atoms in a molecule. Molecular Weights,Weight, Molecular,Weights, Molecular
D001920 Bradykinin A nonapeptide messenger that is enzymatically produced from KALLIDIN in the blood where it is a potent but short-lived agent of arteriolar dilation and increased capillary permeability. Bradykinin is also released from MAST CELLS during asthma attacks, from gut walls as a gastrointestinal vasodilator, from damaged tissues as a pain signal, and may be a neurotransmitter. Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg,Bradykinin Acetate, (9-D-Arg)-Isomer,Bradykinin Diacetate,Bradykinin Hydrochloride,Bradykinin Triacetate,Bradykinin, (1-D-Arg)-Isomer,Bradykinin, (2-D-Pro)-Isomer,Bradykinin, (2-D-Pro-3-D-Pro-7-D-Pro)-Isomer,Bradykinin, (2-D-Pro-7-D-Pro)-Isomer,Bradykinin, (3-D-Pro)-Isomer,Bradykinin, (3-D-Pro-7-D-Pro)-Isomer,Bradykinin, (5-D-Phe)-Isomer,Bradykinin, (5-D-Phe-8-D-Phe)-Isomer,Bradykinin, (6-D-Ser)-Isomer,Bradykinin, (7-D-Pro)-Isomer,Bradykinin, (8-D-Phe)-Isomer,Bradykinin, (9-D-Arg)-Isomer,Arg Pro Pro Gly Phe Ser Pro Phe Arg
D002351 Carrageenan A water-soluble extractive mixture of sulfated polysaccharides from RED ALGAE. Chief sources are the Irish moss CHONDRUS CRISPUS (Carrageen), and Gigartina stellata. It is used as a stabilizer, for suspending COCOA in chocolate manufacture, and to clarify BEVERAGES. Carrageenin,iota-Carrageenan,kappa-Carrageenan,lambda-Carrageenan,iota Carrageenan,kappa Carrageenan,lambda Carrageenan
D004487 Edema Abnormal fluid accumulation in TISSUES or body cavities. Most cases of edema are present under the SKIN in SUBCUTANEOUS TISSUE. Dropsy,Hydrops,Anasarca
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

S Oh-ishi, and I Hayashi, and I Utsunomiya, and M Hayashi, and K Yamaki, and A Yamasu, and T Nakano
T-kininogen in rats with carrageenin-induced inflammation.
December 1986, Biochemical pharmacology,
S Oh-ishi, and I Hayashi, and I Utsunomiya, and M Hayashi, and K Yamaki, and A Yamasu, and T Nakano
Direct radioimmunoassay for rat high molecular weight kininogen. Measurement of immunoreactive high molecular weight kininogen in normal and kininogen deficient plasma.
January 1987, Agents and actions. Supplements,
S Oh-ishi, and I Hayashi, and I Utsunomiya, and M Hayashi, and K Yamaki, and A Yamasu, and T Nakano
Inhibition of carrageenin-induced rat paw oedema by substances causing a reduction of kininogen and prekallikrein in plasma.
January 1971, Acta pharmacologica et toxicologica,
S Oh-ishi, and I Hayashi, and I Utsunomiya, and M Hayashi, and K Yamaki, and A Yamasu, and T Nakano
Characterization of human high molecular weight kininogen. Procoagulant activity associated with the light chain of kinin-free high molecular weight kininogen.
February 1978, The Journal of experimental medicine,
S Oh-ishi, and I Hayashi, and I Utsunomiya, and M Hayashi, and K Yamaki, and A Yamasu, and T Nakano
Primary structure of bovine high molecular weight kininogen: chemical compositions of kinin-free kininogen and peptide fragments released by plasma kallikrein.
October 1975, FEBS letters,
S Oh-ishi, and I Hayashi, and I Utsunomiya, and M Hayashi, and K Yamaki, and A Yamasu, and T Nakano
The high-molecular-mass kininogen deficient rat expresses all kininogen mRNA species, but does not export the high-molecular-mass kininogen synthesized.
October 1988, FEBS letters,
S Oh-ishi, and I Hayashi, and I Utsunomiya, and M Hayashi, and K Yamaki, and A Yamasu, and T Nakano
Plasma high molecular weight kininogen concentration in health and in chosen impairments of haemostasis. Evidence that plasmin uncovers a new antigenic site in high molecular weight kininogen.
October 1979, Thrombosis and haemostasis,
S Oh-ishi, and I Hayashi, and I Utsunomiya, and M Hayashi, and K Yamaki, and A Yamasu, and T Nakano
Mechanism of enhanced kinin release from high molecular weight kininogen by plasma kallikrein after its exposure to plasmin.
July 1992, The Journal of laboratory and clinical medicine,
S Oh-ishi, and I Hayashi, and I Utsunomiya, and M Hayashi, and K Yamaki, and A Yamasu, and T Nakano
Evidence for bradykinin mediation of carrageenin-induced inflammatory pain: a study using kininogen-deficient Brown Norway Katholiek rats.
April 2001, Biochemical pharmacology,
S Oh-ishi, and I Hayashi, and I Utsunomiya, and M Hayashi, and K Yamaki, and A Yamasu, and T Nakano
Tachibana trait: human high molecular weight kininogen deficiency with diminished levels of prekallikrein and low molecular weight kininogen.
September 1985, Nihon Ketsueki Gakkai zasshi : journal of Japan Haematological Society,
Copied contents to your clipboard!